Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension

Arterial wall remodeling underlies increased pulmonary vascular resistance and right heart failure in pulmonary arterial hypertension (PAH). None of the established vasodilator drug therapies for PAH prevents or reverse established arterial wall thickening, stiffening, and hypercontractility. Theref...

Descripción completa

Detalles Bibliográficos
Autor principal: Gerthoffer, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731052/
https://www.ncbi.nlm.nih.gov/pubmed/33287230
http://dx.doi.org/10.3390/ijms21239222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731052/
https://www.ncbi.nlm.nih.gov/pubmed/33287230
http://dx.doi.org/10.3390/ijms21239222

Ejemplares similares